Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Oct;34(10):2199-2209.
doi: 10.1007/s12325-017-0609-5. Epub 2017 Sep 12.

Methodological Aspects in Studies Based on Clinical Routine Data

Affiliations
Review

Methodological Aspects in Studies Based on Clinical Routine Data

Lieven Nils Kennes. Adv Ther. 2017 Oct.

Abstract

Randomized controlled clinical trials are regarded as the gold standard for comparing different clinical interventions, but generally their conduct is operationally cumbersome, time-consuming, and expensive. Studies and investigations based on clinical routine data on the contrary utilize existing data acquired under real-life conditions and are increasingly popular among practitioners. In this paper, methodological aspects of studies based on clinical routine data are discussed. Important limitations and considerations as well as unique strengths of these types of studies are indicated and exemplarily demonstrated in a recent real-case study based on clinical routine data. In addition two simulation studies reveal the impact of bias in studies based on clinical routine data on the type I error rate and false decision rate in favor of the inferior intervention. It is concluded that correctly analyzing clinical routine data yields a valuable addition to clinical research; however, as a result of a lack of statistical foundation, internal validity, and comparability, generalizing results and inferring properties derived from clinical routine data to all patients of interest has to be considered with extreme caution.

Funding: Grünenthal GmbH.

Keywords: Bias; Blinding; Clinical routine data; Internal validity; Randomization.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Relative number of significant study results in the case of no treatment difference (type I error rate)

Similar articles

Cited by

References

    1. Schulz KF, Altman DG, Moher D, for the CONSORT Group CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340:c332. doi: 10.1136/bmj.c332. - DOI - PMC - PubMed
    1. Zwarenstein M, Oxman A. Why are so few randomized trials useful, and what can we do about it? J Clin Epidemiol. 2006;59:1125–1126. doi: 10.1016/j.jclinepi.2006.05.010. - DOI - PubMed
    1. Zuidgeest M, Goetz I, Groenwold R, Irving E, van Thiel G, Grobbee DE. Pragmatic trials and real-world evidence-an introduction to the series. J Clin Epidemiol. 2017 - PubMed
    1. dos Santos Silva I. Cancer epidemiology: principles and methods. Lyon: International Agency for Research on Cancer; 1999.
    1. ICH E9. Statistical principles for clinical trials. 1998. Current version dated 5 Feb 1998. http://www.ich.org. Accessed Sep 2017.

LinkOut - more resources